Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.20 (
alpha-glucosidase
)
4,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
For the design of an enzyme reactor a detailed knowledge of the kinetic parameters of the catalyst under operational conditions is essential. For technical applications high initial substrate concentrations and high degrees of conversions are desirable, in order to save reactor volume and energy in recovery processes. Most of the kinetic data available in the literature have been derived from dilute solutions under initial rate conditions. These data cannot be extrapolated with confidence for technically interesting concentrations because substrate as well as product-inhibition may occur, which would not be observed in dilute solutions and by initial rate measurements. Because of this difficulty effective and fast methods to obtain significant data for technical applications have been developed based on-line rate determinations. Such extensive treatment has proved necessary for the following enzymes: alanine dehydrogenase,
formate dehydrogenase
and
alpha-glucosidase
, indicating that we are dealing with a general phenomenon.
...
PMID:Influence of substrate or product inhibition on the performance of enzyme reactors. 699 11